Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cannon

Showing results (761-770 of 837) with videos related to

Pageof 84
Sort By:
Schizophrenia Research|April 7, 2023
Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosisMatthew A Hagler, Maria Ferrara, Laura A Yoviene Sykes, et al.
Schizophrenia Bulletin Open|June 26, 2023
Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition StatusTanya Tran, Michael J Spilka, Ian M Raugh, et al.
Biological Psychiatry|March 2, 2026
Visual P300 and risk for psychosis onset in youth at clinical high-riskHolly K Hamilton, Brian J Roach, Spero Nicholas, et al.
Schizophrenia Bulletin|August 26, 2025
Decoding Psychosis Risk: Neuroanatomical Correlates of the NAPLS-2 Calculator in the PRONIA CohortLisa-Maria Neuner, Clara Weyer, Lana Kambeitz-Ilankovic, et al.
Brain, Behavior, and Immunity|March 31, 2024
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studiesJonah F Byrne, Colm Healy, Melanie Föcking, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2019
Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study GroupPaula Marincola Smith, Jordan Baechle, Carmen C Solórzano, et al.
Frontiers in Psychiatry|October 2, 2020
Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle ParadigmKristin S Cadenhead, Erica Duncan, Jean Addington, et al.
Cell Press Blue|June 22, 2026
Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progressionAshley L Kiemen, Valentina Matos, Cristina Almagro-Pérez, et al.
Schizophrenia Bulletin|April 24, 2016
Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for PsychosisDanielle McLaughlin, Ricardo E Carrión, Andrea M Auther, et al.
Clinical EEG and Neuroscience|November 18, 2024
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Pageof 84

Showing results (761-770 of 837) with videos related to

Sort By:
Pageof 84
Schizophrenia Research|April 7, 2023
Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosisMatthew A Hagler, Maria Ferrara, Laura A Yoviene Sykes, et al.
Schizophrenia Bulletin Open|June 26, 2023
Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition StatusTanya Tran, Michael J Spilka, Ian M Raugh, et al.
Biological Psychiatry|March 2, 2026
Visual P300 and risk for psychosis onset in youth at clinical high-riskHolly K Hamilton, Brian J Roach, Spero Nicholas, et al.
Schizophrenia Bulletin|August 26, 2025
Decoding Psychosis Risk: Neuroanatomical Correlates of the NAPLS-2 Calculator in the PRONIA CohortLisa-Maria Neuner, Clara Weyer, Lana Kambeitz-Ilankovic, et al.
Brain, Behavior, and Immunity|March 31, 2024
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studiesJonah F Byrne, Colm Healy, Melanie Föcking, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 7, 2019
Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study GroupPaula Marincola Smith, Jordan Baechle, Carmen C Solórzano, et al.
Frontiers in Psychiatry|October 2, 2020
Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle ParadigmKristin S Cadenhead, Erica Duncan, Jean Addington, et al.
Cell Press Blue|June 22, 2026
Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progressionAshley L Kiemen, Valentina Matos, Cristina Almagro-Pérez, et al.
Schizophrenia Bulletin|April 24, 2016
Functional Capacity Assessed by the Map Task in Individuals at Clinical High-Risk for PsychosisDanielle McLaughlin, Ricardo E Carrión, Andrea M Auther, et al.
Clinical EEG and Neuroscience|November 18, 2024
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for PsychosisHolly K Hamilton, Brian J Roach, Peter M Bachman, et al.
Pageof 84